Page last updated: 2024-10-30

mecamylamine and Peripheral Nerve Diseases

mecamylamine has been researched along with Peripheral Nerve Diseases in 2 studies

Mecamylamine: A nicotinic antagonist that is well absorbed from the gastrointestinal tract and crosses the blood-brain barrier. Mecamylamine has been used as a ganglionic blocker in treating hypertension, but, like most ganglionic blockers, is more often used now as a research tool.

Research Excerpts

ExcerptRelevanceReference
"Physostigmine has different effects on allodynia and nociception, which suggests that different cholinergic (muscarinic) mechanisms may be involved in neuropathic and nociceptive pain."3.70Systemic physostigmine shows antiallodynic effects in neuropathic rats. ( Kalso, E; Kontinen, VK; Paananen, S; Pöyhiä, R; Xu, M, 1999)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pöyhiä, R1
Xu, M1
Kontinen, VK1
Paananen, S1
Kalso, E1
Hentall, ID1
Sagen, J1

Other Studies

2 other studies available for mecamylamine and Peripheral Nerve Diseases

ArticleYear
Systemic physostigmine shows antiallodynic effects in neuropathic rats.
    Anesthesia and analgesia, 1999, Volume: 89, Issue:2

    Topics: Analgesics; Analgesics, Opioid; Animals; Atropine; Cholinergic Antagonists; Dose-Response Relationsh

1999
Spinal CSF from rats with painful peripheral neuropathy evokes catecholamine release from chromaffin cells in vitro.
    Neuroscience letters, 2000, Jun-02, Volume: 286, Issue:2

    Topics: Adrenal Medulla; Animals; Catecholamines; Cattle; Cells, Cultured; Cerebrospinal Fluid; Cerebrospina

2000